Literature DB >> 27389781

Laboratory Response to Ebola - West Africa and United States.

Tara K Sealy1, Bobbie R Erickson, Céline H Taboy, Ute Ströher, Jonathan S Towner, Sharon E Andrews, Laura E Rose, Elizabeth Weirich, Luis Lowe, John D Klena, Christina F Spiropoulou, Mark A Rayfield, Brian H Bird.   

Abstract

The 2014-2016 Ebola virus disease (Ebola) epidemic in West Africa highlighted the need to maintain organized laboratory systems or networks that can be effectively reorganized to implement new diagnostic strategies and laboratory services in response to large-scale events. Although previous Ebola outbreaks enabled establishment of critical laboratory practice safeguards and diagnostic procedures, this Ebola outbreak in West Africa highlighted the need for planning and preparedness activities that are better adapted to emerging pathogens or to pathogens that have attracted little commercial interest. The crisis underscored the need for better mechanisms to streamline development and evaluation of new diagnostic assays, transfer of material and specimens between countries and organizations, and improved processes for rapidly deploying health workers with specific laboratory expertise. The challenges and events of the outbreak forced laboratorians to examine not only the comprehensive capacities of existing national laboratory systems to recognize and respond to events, but also their sustainability over time and the mechanisms that need to be pre-established to ensure effective response. Critical to this assessment was the recognition of how response activities (i.e., infrastructure support, logistics, and workforce supplementation) can be used or repurposed to support the strengthening of national laboratory systems during the postevent transition to capacity building and recovery. This report compares CDC's domestic and international laboratory response engagements and lessons learned that can improve future responses in support of the International Health Regulations and Global Health Security Agenda initiatives.The activities summarized in this report would not have been possible without collaboration with many U.S. and international partners (http://www.cdc.gov/vhf/ebola/outbreaks/2014-west-africa/partners.html).

Entities:  

Mesh:

Year:  2016        PMID: 27389781     DOI: 10.15585/mmwr.su6503a7

Source DB:  PubMed          Journal:  MMWR Suppl        ISSN: 2380-8942


  12 in total

1.  Clinical Laboratory Equipment Manufacturer Policies on Highly Hazardous Communicable Diseases.

Authors:  Jocelyn J Herstein; Sean A Buehler; Aurora B Le; John J Lowe; Peter C Iwen; Shawn G Gibbs
Journal:  Public Health Rep       Date:  2019-06-20       Impact factor: 2.792

2.  Clinical Surveillance and Evaluation of Suspected Ebola Cases in a Vaccine Trial During an Ebola Epidemic: The Sierra Leone Trial to Introduce a Vaccine Against Ebola.

Authors:  Muhammad-Abbas Conteh; Susan T Goldstein; Haja R Wurie; Jane Gidudu; Durodami Radcliffe Lisk; Rosalind J Carter; Jane F Seward; Lee M Hampton; David Wang; Lauren E Andersen; Melissa Arvay; Stephanie J Schrag; Peter Dawson; Augustin E Fombah; Carey R Petrie; Daniel R Feikin; James B W Russell; Robert Lindblad; S A S Kargbo; Mohamed Samai; Barbara E Mahon
Journal:  J Infect Dis       Date:  2018-05-18       Impact factor: 5.226

3.  Strengthening laboratory networks in the Central Africa region: A milestone for epidemic preparedness and response.

Authors:  Patrick A Njukeng; Charles Njumkeng; Callistus Ntongowa; Mohammed Abdulaziz
Journal:  Afr J Lab Med       Date:  2022-05-19

Review 4.  Clinical Laboratory Biosafety Gaps: Lessons Learned from Past Outbreaks Reveal a Path to a Safer Future.

Authors:  Nancy E Cornish; Nancy L Anderson; Diego G Arambula; Matthew J Arduino; Andrew Bryan; Nancy C Burton; Bin Chen; Beverly A Dickson; Judith G Giri; Natasha K Griffith; Michael A Pentella; Reynolds M Salerno; Paramjit Sandhu; James W Snyder; Christopher A Tormey; Elizabeth A Wagar; Elizabeth G Weirich; Sheldon Campbell
Journal:  Clin Microbiol Rev       Date:  2021-06-09       Impact factor: 50.129

5.  South African Ebola diagnostic response in Sierra Leone: A modular high biosafety field laboratory.

Authors:  Janusz T Paweska; Petrus Jansen van Vuren; Gunther H Meier; Chantel le Roux; Ousman S Conteh; Alan Kemp; Cardia Fourie; Prabha Naidoo; Serisha Naicker; Phumza Ohaebosim; Nadia Storm; Orienka Hellferscee; Lisa K Ming Sun; Busisiwe Mogodi; Nishi Prabdial-Sing; Desiree du Plessis; Deidre Greyling; Shayne Loubser; Mark Goosen; Stewart D McCulloch; Terence P Scott; Alexandra Moerdyk; Wesley Dlamini; Kelfala Konneh; Idrissa L Kamara; Dauda Sowa; Samuel Sorie; Brima Kargbo; Shabir A Madhi
Journal:  PLoS Negl Trop Dis       Date:  2017-06-19

6.  Determining the effect of different environmental conditions on Ebola virus viability in clinically relevant specimens.

Authors:  Bernadett Palyi; Nora Magyar; Judit Henczko; Balint Szalai; Agnes Farkas; Thomas Strecker; Maria Takacs; Zoltan Kis
Journal:  Emerg Microbes Infect       Date:  2018-03-29       Impact factor: 7.163

7.  Ebola Response Impact on Public Health Programs, West Africa, 2014-2017.

Authors:  Barbara J Marston; E Kainne Dokubo; Amanda van Steelandt; Lise Martel; Desmond Williams; Sara Hersey; Amara Jambai; Sakoba Keita; Tolbert G Nyenswah; John T Redd
Journal:  Emerg Infect Dis       Date:  2017-12       Impact factor: 6.883

8.  Ebola exposure, illness experience, and Ebola antibody prevalence in international responders to the West African Ebola epidemic 2014-2016: A cross-sectional study.

Authors:  Catherine F Houlihan; Catherine R McGowan; Steve Dicks; Marc Baguelin; David A J Moore; David Mabey; Chrissy H Roberts; Alex Kumar; Dhan Samuel; Richard Tedder; Judith R Glynn
Journal:  PLoS Med       Date:  2017-05-16       Impact factor: 11.069

9.  Infection Rates and Risk Factors for Infection Among Health Workers During Ebola and Marburg Virus Outbreaks: A Systematic Review.

Authors:  Saranya A Selvaraj; Karen E Lee; Mason Harrell; Ivan Ivanov; Benedetta Allegranzi
Journal:  J Infect Dis       Date:  2018-11-22       Impact factor: 5.226

10.  Contributions of the US Centers for Disease Control and Prevention in Implementing the Global Health Security Agenda in 17 Partner Countries.

Authors:  Arthur G Fitzmaurice; Michael Mahar; Leah F Moriarty; Maureen Bartee; Mitsuaki Hirai; Wenshu Li; A Russell Gerber; Jordan W Tappero; Rebecca Bunnell
Journal:  Emerg Infect Dis       Date:  2017-12       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.